Form4.ai tracks every SEC insider trade in real time. See every ANTX insider filing with a free account — no card.
See every ANTX insider filing — free account, no card.
Free accountAN2 Therapeutics, Inc. (ANTX) has 10 SEC Form 4 insider filings on record in the last 90 days. That includes 1 insider purchase totalling $12K, and 4 sales totalling $318K. Most recent filing: Oct. 13, 2026.
Open-market value, last 90 days
Form 4 filings by type, last 90 days
| Date | Insider | Trade | Value | Price since buy |
|---|---|---|---|---|
| Oct 13, 2026 SEC filing | Martin Patricia A. Director | Grant / award | — | — |
| Oct 13, 2026 SEC filing | Marks Gilbert Lynn Director | Grant / award | — | — |
| Oct 13, 2026 SEC filing | Aziz Kabeer Director | Grant / award | — | — |
Create a free account to see all 10 ANTX filings from the last 90 days. No card needed.
Create free accountWant ANTX insider buys the moment they're filed, with Telegram alerts? Try Pro free for 7 days
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.